Target intelligence / Profile preview

Endosomal membrane of antigen-presenting cell

Molecular classification
Other (subcellular membrane compartment, not a molecule, protein, or receptor)
01

Overview

The **endosomal membrane of antigen-presenting cells** is the lipid bilayer boundary of endosomes within professional immune cells responsible for internalizing, processing, and presenting antigens. Key processes occur at or across this membrane, including regulated antigen translocation into the cytosol (e.g., via translocon Sec61), controlled proteolysis and peptide loading onto major histocompatibility complex (MHC) molecules, oxidative modification by NADPH oxidase (NOX2)-mediated ROS leading to lipid peroxidation and antigen release, and the spatial organization for immune signaling. While essential for antigen presentation and immune responses, the membrane itself is not a drug target; rather, specific proteins or pathways associated with the membrane are therapeutically targeted in cancer, infectious, and autoimmune diseases. Overactivation or uncontrolled disruption of this membrane can cause cellular toxicity and immune dysregulation.

Other names
Endosomal membraneEndosome membrane of APCEndocytic vesicle membrane (within context of antigen-presenting cells)
02

Mechanism of action

For ROS-inducing drugs: Increase lipid peroxidation leading to antigen release into cytosol for cross-presentation. For gene therapy agents: Disrupt endosomal integrity to deliver nucleic acids.

03

Biological functions

Antigen processingAntigen cross-presentationEndocytosisIntracellular traffickingPeptide loading onto MHC moleculesRegulation of proteolytic activityImmune response
04

Disease associations

Cancer (via manipulation of cross-presentation for immunotherapy)Infection (pathogen evasion or immune activation)Autoimmune disease (regulation of self-antigen presentation)Other (general immune modulation)
05

Safety considerations

Inducing uncontrolled endosomal/lysosomal membrane damage can trigger cell death, uncontrolled leakage of lysosomal enzymes (cathepsins), and danger signals (NLRP3 inflammasome activation, pyroptosis)Non-specific endosomal disruption can cause toxicity in gene therapy or immunomodulation
06

Interacting drugs

For membrane-associated proteins, experimental cancer immunotherapies that promote endosomal antigen release via ROS modulation

1 more in the full profile.

07

Biomarkers

For associated proteins: Upregulation of NADPH oxidase (NOX2), Sec61 localization or activity

Beyond the preview

Go deeper on Endosomal membrane of antigen-presenting cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosomal membrane of antigen-presenting cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call